Pharma News, 2025

Glycomine raises $115m to advance rare disease therapy into Phase IIb

One dose of experimental drug nearly wipes out stealthy cholesterol in 'remarkable' trial

The US Food and Drug Administration (FDA) has approved the injectable antibiotics Piperacillin and Tazobactam for use in B Braun Medical’s Duplex drug delivery system.

Ruvidar (TLD-1433) More Effective in the Treatment of Herpes than FDA-Approved Treatments

Shares in many large drugmakers fell Wednesday on the president’s threat, which could further challenge an already battered sector.

US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company valued at $127.54 million, and Makana Therapeutics, Inc., specializing in xenotransplantation, have entered into a research collaborati...

Job cuts at the FDA spark concern, with Robert Califf saying the agency as we know it is “finished.”

Lyme disease infects about 476,000 people in the United States each year and can lead to severe complications such as ongoing fatigue and joint issues. However, no human vaccine is yet commercially av...

China’s National Medical Products Administration (NMPA) has approved the marketing authorisation application of Santen Pharmaceutical’s Tapcom to treat individuals with open-angle glaucoma...

Novo Nordisk, the Danish pharmaceutical leader, announced a R$6.4 billion ($1.12 billion) investment in its Montes Claros facility in Minas Gerais, Brazil. This expansion aims to double the pl...

ABL Bio has announced a global licensing agreement with GSK, allowing the latter to develop medicines for neurodegenerative conditions.